3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Sponsor Class
OTHER
5
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other neoplasm
1
Genitourinary
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenomatous Polyps
1
Interventions
Radiotherapy
214
Cisplatin
180
Cyclophosphamide
169
Doxorubicin
138
Vincristine
127
Paclitaxel
125
Filgrastim
121
Etoposide
104
Carboplatin
100
Methotrexate
83
Gemcitabine
82
Docetaxel
78
Cytarabine
78
Gene Expression Profiling
74
Fluorouracil
74
Prednisone
71
Granulocyte Colony-Stimulating Factor
66
Dexamethasone
66
Leucovorin
62
Polymerase Chain Reaction
47
Immunohistochemistry
46
Microarray Analysis
40
Daunorubicin
38
Irinotecan
37
Ifosfamide
37
Temozolomide
35
Cetuximab
33
Amplified Fragment Length Polymorphism Analysis
33
Peripheral Blood Stem Cell Transplantation
32
Mercaptopurine
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
NETWORK
×
alpha-Tocopherol
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts
NCT00006392
2015-11-20
SELECT
SWOG Cancer Research Network
Phase 3
Completed
35,533 enrolled
20 charts